Call For Papers for Special Session: 12th IEEE International Conference on BioInformatics and BioEngineering

11 - 13 November 2011, Larnaca, Cyprus.
Call For Papers for Special Session on Computational solutions to large-scale data management and analysis in translational, personalized and predictive medicine.
Medicine is undergoing a revolution that is transforming the nature of healthcare from reactive to preventive. The changes are catalyzed by a new systems approach to disease that focuses on integrated diagnosis, treatment and prevention of disease in individuals. This is expected to replace our current mode of medicine over the coming years with a personalized and predictive treatment. While the goal is clear, the path is fraught with challenges.

Our success in addressing these challenges depends on our ability to properly interpret the large-scale, high-dimensional data sets that are generated by modern technologies, since it is becoming increasingly clear that a comprehensive analysis of biological systems requires the integration of all fingerprints of cellular function: genome sequence, maps of gene expression, protein expression, metabolic output, and in vivo enzymatic expression (activity). This need for integration is especially clear in the case of complex, multifactorial diseases, such as cancer.

At the same time the Virtual Physiological Human (VPH) framework aims to define methods and technologies that once fully established will enable the investigation of the human body as a whole, eventually leading to a better healthcare system that offers personalized care solutions, more holistic approach to medicine and a preventative approach to the treatment of disease. Although consensus exists about what the fundamental tools are (integration of highthroughput data from several biologic scales, high-definition imaging, and computational modeling), no such consensus exists as to what are the most promising scientific approaches in responding to these challenges.

A growing awareness is found that, despite significant technological advances in various domains of relevance, fundamental obstacles separate systems biology from clinical applications. Bridging these gaps will require a focused and concerted effort in addressing various questions, such as:

  • What defines systems medicine as a discipline?
  • What should it seek to accomplish?
  • How to develop optimal frameworks for large-scale data sharing?
  • How to exploit data from hospital information systems, EHRs and PHRs and how to curate these data?
  • How should knowledge from disparate sources be assembled into ontologies relevant to systems medicine?
  • How are multiscale data to be synthesized by corresponding multiscale models?
  • How should models be represented, stored, managed and shared?
  • What is the burden of proof that such models are valid and predictive of clinically relevant outcomes?

Furthermore, because of the necessary multiscale nature of the models bridging embedded levels of organization from molecules, organelles, cells, tissues, organs, and all the way to individuals, environmental factors, populations, and ecosystems, systems medicine aims to discover and select the key factors at each level and integrate them into models of translational relevance, which include measurable readouts and clinical predictions.

The Special Session will build on experiences as well as technological and scientific developments stemming from some flagship projects funded by the EU under the FP7 framework programme aiming to bring together researches working in the fields of infrastructures and technologies for integrative biomedical research, ICT for predictive and translational medicine and the VPH at large.

In addition the Special Session invites original research work in all aspects of Cancer Informatics with a focus on revealing progress, and challenges in some of core domains that support the vision of predictive and personalised medicine in the domain of cancer.

Organisers:

  • Prof. Manolis Tsiknakis, TEI Crete and FORTH
  • Dr. Kostas Marias, FORTH
  • Dr. Vangelis Sakkalis, FORTH
  • Prof. Dr. Norbert Graf, University of Saarland
  • Dr. Anca Bucur, Philips Research, Eindhoven, NL
  • Prof Constantinos S. Pattichis, University of Cyprus

Projects:
The Special session will draw upon experiences form some flagship EU funded projects such as:

Important Dates:
Paper Submission Deadline: July 15, 2012
Paper Notification: August 15, 2012
Camera Ready Paper: September 8, 2012

For further information and registration, please visit:
http://bibe2012.cs.ucy.ac.cy

About IEEE International Conference on BioInformatics and BioEngineering
The annual IEEE International Conference on Bioinformatics and Bioengineering cover complementary disciplines that hold great promise for the advancement of research and development in complex medical and biological systems, agriculture, environment, public health, drug design, and so on. Research and development in these two areas are impacting the science and technology of fields such as medicine, food production, forensics, etc. by advancing fundamental concepts in molecular biology and in medicine, by helping us understand living organisms at multiple levels, by developing innovative implants and bio-prosthetics, and by improving tools and techniques for the detection, prevention and treatment of 1diseases. The BIBE series provides a common platform for the cross fertilization of ideas, and to help shape knowledge and scientific achievements by bridging these two very important and complementary disciplines into an interactive and attractive forum. Keeping this objective in mind, BIBE solicits original contributions in the following non exclusive lists of areas.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...